Niall J. Lennon

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Structural variant discovery and diagnostic impact in rare diseases from short-read and long-read sequencing

  medRxiv · 2026-06-24

• Abstract 495: Single-cell multiomic drug response profiling of PRISM-multiplexed cancer cell lines sequenced with SBX.

  Cancer Research · 2026-04-03

• Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study

  The American Journal of Human Genetics · 2026-03-23 · 1 citations

• The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments

  The American Journal of Human Genetics · 2026-03-23 · 3 citations

• Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study

  Nature Cancer · 2026-01-26 · 1 citations

• Supplemental Figure 5 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 1 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 6 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 3 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 2 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 4 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations

  Blood · 2025-11-03 · 4 citations

• Toward Same-Day Genome Sequencing in the Critical Care Setting

  New England Journal of Medicine · 2025-10-15 · 10 citations

• Population-scale Long-read Sequencing in the All of Us Research ProgramPreprint

  medRxiv · 2025-10-05 · 3 citations

• The Somatic Mosaicism across Human Tissues Network

  Nature · 2025-07-02 · 42 citations

• Whole-Genome Sequencing is a Viable Replacement for Chromosomal Microarray and Fragile X PCR TestingPreprint

  medRxiv · 2025-05-25 · 1 citations

• <i>Celeste</i> : A cloud-based genomics infrastructure with variant-calling pipeline suited for population-scale sequencing projectsPreprint

  medRxiv · 2025-05-01

• Broad, Agnostic Pathogen Detection through Metagenomic Next Generation Sequencing (mNGS) of Cerebrospinal Fluid (CSF) to Diagnose CNS Infections (P7-10.007)

  Neurology · 2025-04-07